Latest Breaking News On - Exchange commission as exhibit - Page 1 : comparemela.com

Nicholas Financial : Special Shareholder Meeting Conducted April 15, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT .

Aileron Therapeutics : Management Change/Compensation - Form 8-K -March 29, 2024 at 08:05 am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;.

Compugen : Results of the Annual General Meeting of Shareholders held on September 20, 2023 -September 21, 2023 at 07:07 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF.

Form 8-K ATAI Life Sciences N.V. For: Aug 10

ATAI LIFE SCIENCES N.V. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition. On May 11, 2023, ATAI Life Sciences N.V. issued a press release announcing its financial results for the quarter ended March 31, 2023. | May 11, 2023